 Kimberly Simmons
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 32 | 2026 | 3890 | 3.630 |
Why?
| | Autoantibodies | 12 | 2025 | 1501 | 1.890 |
Why?
| | Insulin-Secreting Cells | 5 | 2023 | 388 | 1.480 |
Why?
| | Antibodies, Monoclonal, Humanized | 6 | 2026 | 985 | 1.230 |
Why?
| | Hypoglycemic Agents | 3 | 2026 | 1387 | 0.720 |
Why?
| | Autoimmunity | 4 | 2026 | 926 | 0.670 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2021 | 37 | 0.660 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 37 | 0.660 |
Why?
| | Prediabetic State | 1 | 2023 | 245 | 0.640 |
Why?
| | HLA-DQ beta-Chains | 1 | 2020 | 57 | 0.630 |
Why?
| | Health Fairs | 1 | 2019 | 10 | 0.610 |
Why?
| | Insulin | 5 | 2023 | 2507 | 0.570 |
Why?
| | Celiac Disease | 2 | 2022 | 308 | 0.510 |
Why?
| | Endocrinology | 3 | 2024 | 77 | 0.500 |
Why?
| | Child | 23 | 2026 | 22633 | 0.490 |
Why?
| | Insulin Antibodies | 1 | 2016 | 103 | 0.480 |
Why?
| | Dried Blood Spot Testing | 1 | 2016 | 126 | 0.460 |
Why?
| | Adolescent | 19 | 2026 | 22428 | 0.460 |
Why?
| | Blood Glucose | 2 | 2026 | 2327 | 0.430 |
Why?
| | HLA-D Antigens | 1 | 2014 | 30 | 0.430 |
Why?
| | Diet Therapy | 1 | 2014 | 37 | 0.420 |
Why?
| | Antibodies | 1 | 2015 | 401 | 0.390 |
Why?
| | Glucose Tolerance Test | 2 | 2026 | 361 | 0.360 |
Why?
| | Islets of Langerhans | 5 | 2024 | 833 | 0.360 |
Why?
| | Bone Density | 1 | 2015 | 482 | 0.350 |
Why?
| | Mass Screening | 1 | 2019 | 1347 | 0.330 |
Why?
| | Child, Preschool | 11 | 2026 | 11787 | 0.320 |
Why?
| | Humans | 36 | 2026 | 144759 | 0.320 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 846 | 0.300 |
Why?
| | Diabetes Complications | 2 | 2022 | 222 | 0.290 |
Why?
| | Infant | 10 | 2026 | 10034 | 0.280 |
Why?
| | Diabetic Ketoacidosis | 3 | 2025 | 210 | 0.260 |
Why?
| | C-Peptide | 2 | 2026 | 189 | 0.260 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2026 | 15 | 0.240 |
Why?
| | Risk Assessment | 3 | 2023 | 3671 | 0.240 |
Why?
| | Hypothyroidism | 1 | 2026 | 67 | 0.230 |
Why?
| | Disease Progression | 5 | 2024 | 2847 | 0.230 |
Why?
| | HLA Antigens | 2 | 2025 | 225 | 0.230 |
Why?
| | Male | 16 | 2026 | 72315 | 0.230 |
Why?
| | Thyroid Gland | 1 | 2026 | 88 | 0.230 |
Why?
| | Herpesvirus 4, Human | 1 | 2026 | 176 | 0.220 |
Why?
| | Female | 16 | 2026 | 78271 | 0.220 |
Why?
| | Age of Onset | 3 | 2025 | 551 | 0.210 |
Why?
| | Immunotherapy | 1 | 2026 | 653 | 0.170 |
Why?
| | Obesity Management | 1 | 2020 | 7 | 0.170 |
Why?
| | Hyperglycemia | 1 | 2024 | 375 | 0.160 |
Why?
| | Diagnostic Techniques, Endocrine | 1 | 2019 | 14 | 0.150 |
Why?
| | Blood Specimen Collection | 1 | 2019 | 38 | 0.150 |
Why?
| | Clinical Protocols | 1 | 2021 | 282 | 0.150 |
Why?
| | Quality of Life | 2 | 2023 | 3185 | 0.140 |
Why?
| | Methylation | 1 | 2019 | 242 | 0.140 |
Why?
| | Young Adult | 5 | 2025 | 14105 | 0.140 |
Why?
| | Haplotypes | 1 | 2020 | 490 | 0.140 |
Why?
| | Nutritional Status | 1 | 2021 | 354 | 0.140 |
Why?
| | Cell Death | 1 | 2019 | 383 | 0.130 |
Why?
| | Disease Susceptibility | 1 | 2019 | 348 | 0.130 |
Why?
| | Adult | 6 | 2026 | 40449 | 0.130 |
Why?
| | Community Health Services | 1 | 2019 | 233 | 0.130 |
Why?
| | Hypophosphatemia | 1 | 2017 | 17 | 0.130 |
Why?
| | Alleles | 1 | 2020 | 879 | 0.130 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2016 | 27 | 0.120 |
Why?
| | Radioimmunoassay | 1 | 2016 | 165 | 0.120 |
Why?
| | Risk | 1 | 2019 | 911 | 0.120 |
Why?
| | Colorado | 3 | 2024 | 4564 | 0.120 |
Why?
| | Disease Management | 1 | 2020 | 645 | 0.120 |
Why?
| | Infant Formula | 1 | 2017 | 71 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 616 | 0.120 |
Why?
| | Bone Diseases | 1 | 2017 | 61 | 0.120 |
Why?
| | Caregivers | 1 | 2025 | 1049 | 0.120 |
Why?
| | Patient Education as Topic | 1 | 2021 | 780 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2023 | 1560 | 0.110 |
Why?
| | Prospective Studies | 2 | 2026 | 7990 | 0.110 |
Why?
| | Pediatrics | 2 | 2024 | 1114 | 0.110 |
Why?
| | Abatacept | 1 | 2014 | 56 | 0.110 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 488 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2014 | 40 | 0.110 |
Why?
| | Early Medical Intervention | 1 | 2014 | 61 | 0.100 |
Why?
| | Niacinamide | 1 | 2014 | 86 | 0.100 |
Why?
| | Diabetic Nephropathies | 1 | 2017 | 318 | 0.100 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2019 | 699 | 0.100 |
Why?
| | Health Status | 1 | 2019 | 836 | 0.100 |
Why?
| | Prevalence | 3 | 2026 | 2834 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 637 | 0.100 |
Why?
| | Secondary Prevention | 1 | 2014 | 254 | 0.100 |
Why?
| | Immunoconjugates | 1 | 2014 | 132 | 0.090 |
Why?
| | Autoantigens | 1 | 2015 | 429 | 0.090 |
Why?
| | Chronic Disease | 1 | 2019 | 1813 | 0.090 |
Why?
| | Primary Prevention | 1 | 2014 | 220 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 876 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 2 | 2025 | 2363 | 0.090 |
Why?
| | Treatment Outcome | 1 | 2026 | 11679 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 463 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5868 | 0.070 |
Why?
| | Middle Aged | 3 | 2025 | 35875 | 0.070 |
Why?
| | Risk Factors | 1 | 2023 | 10779 | 0.070 |
Why?
| | Consensus | 2 | 2022 | 488 | 0.070 |
Why?
| | Biomarkers | 1 | 2019 | 4271 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1720 | 0.070 |
Why?
| | Societies, Medical | 2 | 2024 | 887 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2022 | 1985 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2022 | 668 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2015 | 6429 | 0.050 |
Why?
| | CD3 Complex | 1 | 2023 | 111 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2023 | 172 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2023 | 1982 | 0.040 |
Why?
| | Hypoglycemia | 1 | 2026 | 477 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 331 | 0.040 |
Why?
| | Perception | 1 | 2023 | 377 | 0.040 |
Why?
| | Databases, Factual | 1 | 2026 | 1486 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 549 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 2029 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2023 | 672 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 198 | 0.030 |
Why?
| | ROC Curve | 1 | 2019 | 614 | 0.030 |
Why?
| | Rickets | 1 | 2017 | 10 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2026 | 5408 | 0.030 |
Why?
| | Phosphorus | 1 | 2017 | 99 | 0.030 |
Why?
| | Aged | 1 | 2016 | 25913 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 145 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 1109 | 0.030 |
Why?
| | Parents | 1 | 2023 | 1403 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2115 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2947 | 0.020 |
Why?
| | Calcium | 1 | 2017 | 1183 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1356 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6048 | 0.010 |
Why?
| | Animals | 1 | 2015 | 38058 | 0.010 |
Why?
|
|
Simmons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|